Market open · Delayed intraday data · 11:39 AM ET
Last update: Nov 18, 2026, 11:32 AM ET
Repligen Corporation
▼ 6.2% on Oct 30, 2026

Why Repligen Corporation (RGEN) Stock Fell 6.2% on Oct 30, 2026

The clearest new catalyst: Convertible Notes Offering.

Researched by BestStocks Market Desk · Updated Nov 2, 2026
Prior close
$188.64
Oct 30, 2026 close
$176.94
Change
−$11.70
-6.20%
Rel. volume
4.0×
4.5M shares

Why did RGEN stock fall?

Repligen Corporation fell 6.2% on October 30, 2026, following the announcement of a $1 billion private convertible senior notes offering due 2031, coupled with a concurrent $120 million share repurchase program. The convertible debt issuance, which carries a 0.25% coupon, triggered dilution concerns and arbitrage-related selling pressure typical of large debt offerings, with intraday volume surging to 1.55 million shares—7.71x normal levels at that point in the session.

  • Convertible Notes Offering: Repligen announced $1.0 billion in aggregate principal amount of 0.25% convertible senior notes due 2031. Large convertible issuances typically create short-term dilution and arbitrage-related selling pressure.
  • Share Repurchase Program: The company stated it intended to use approximately $120 million of the net proceeds to repurchase common stock from certain purchasers of the notes at $188.64 per share, signaling potential dilution mechanics.
  • Post-Earnings Volatility: The debt announcement followed closely after Repligen's Q3 2026 earnings report released on October 27, contributing to ongoing market digestion and valuation adjustments.
Note: The published narrative cites an intraday decline from $188.64 to $172.49 (8.56%), but the confirmed session move is −6.2% close-to-close; the intraday low does not represent the final close.
Researched from primary and established sources on Nov 2, 2026.

Initial detection

BestStocks first flagged RGEN intraday on Oct 30, 2026; this analysis was finalized after the close using the confirmed −6.2% session move and additional catalyst research.

Show the initial intraday note
Risk-6.2%high confidence

Repligen announced a $1 billion private convertible senior notes offering (Globe Newswire), triggering an 8.56% intraday decline from $188.64 to $172.49. Volume surged to 1.55M shares—7.71x the typical level at this stage of the session—signaling heavy seller participation.

Source: fmp_intraday

What to watch next: Repligen earnings on November 3, 2026 (consensus EPS $0.46); management commentary on use of proceeds and any updated guidance.

Other developments that session

Filingshigh confidence

Repligen Corporation (RGEN) filed its Q3 2026 10-Q on October 30, 2026. The filing precedes earnings guidance scheduled for early November.

Source: filing_snapshots
News

Repligen issues $1 billion private convertible senior notes through exchange and subscription agreements.

Source: Globe Newswire

Frequently asked questions

Why did Repligen Corporation (RGEN) stock fall on Oct 30, 2026?

Repligen Corporation fell 6.2% on October 30, 2026, following the announcement of a $1 billion private convertible senior notes offering due 2031, coupled with a concurrent $120 million share repurchase program. The convertible debt issuance, which carries a 0.25% coupon, triggered dilution concerns and arbitrage-related selling pressure typical of large debt offerings, with intraday volume surging to 1.55 million shares—7.71x normal levels at that point in the session.

How much did RGEN stock fall on Oct 30, 2026?

RGEN fell 6.2% during the Oct 30, 2026 trading session.

What were the main drivers behind RGEN's move?

Convertible Notes Offering; Share Repurchase Program; Post-Earnings Volatility.

This is an archived analysis of RGEN's Oct 30, 2026 session.
See RGEN's latest changes →
Educational research tool — not personalized investment advice. Figures reflect the Oct 30, 2026 session as first analyzed.